Provided by Tiger Trade Technology Pte. Ltd.

Phio Pharmaceuticals

1.13
+0.01801.62%
Volume:69.79K
Turnover:78.69K
Market Cap:13.10M
PE:-0.78
High:1.15
Open:1.11
Low:1.09
Close:1.11
52wk High:4.19
52wk Low:0.8127
Shares:11.62M
Float Shares:11.55M
Volume Ratio:0.83
T/O Rate:0.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4378
EPS(LYR):-1.4535
ROE:-76.36%
ROA:-46.65%
PB:0.80
PE(LYR):-0.78

Loading ...

Phio Pharmaceuticals to present at Renmark virtual non-deal roadshow, host live Q&A

Reuters
·
May 26

Phio Pharmaceuticals to join Force Family Office fireside chat on skin cancer innovations

Reuters
·
May 12

Phio Pharma Q1 EPS $(0.34) Misses $(0.23) Estimate

Benzinga
·
May 08

Phio Pharmaceuticals Q1 FY26 net loss widens to $4 million; R&D expenses rise 215% to $2.8 million

Reuters
·
May 08

Phio Pharma to present at Renmark virtual non-deal roadshow, hosts live Q&A

Reuters
·
Apr 23

Phio Pharmaceuticals to join Force Family Office fireside chat on skin cancer program

Reuters
·
Apr 13

Phio CEO to present at Centri Capital Conference, highlighting INTASYL immuno-oncology strategy

Reuters
·
Apr 09

Phio Pharmaceuticals Establishes New At-the-Market Equity Program

TIPRANKS
·
Apr 09

Phio Pharmaceuticals enters $6.36 million at-the-market equity distribution agreement with H.C. Wainwright

Reuters
·
Apr 09

Phio Pharmaceuticals Corp - Enters at the Market Offering Agreement With H.c. Wainwright on April 8, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 09

Phio Pharmaceuticals Corp - to Offer up to $6.36 Mln of Shares Under Sales Agreement - SEC Filing

THOMSON REUTERS
·
Apr 09

Phio Pharmaceuticals Secures cGMP Manufacturing for Clinical Supply

TIPRANKS
·
Mar 30

Phio Pharmaceuticals Corp - Enters Agreement With U.S. Cgmp Manufacturer for Ph-762 - SEC Filing

THOMSON REUTERS
·
Mar 30

Phio signs U.S. cGMP manufacturing deal for PH-762 clinical, commercial supply

Reuters
·
Mar 30

Phio Pharmaceuticals reports 65% pathological response rate in Phase 1b trial of PH-762 for cutaneous squamous cell carcinoma

Reuters
·
Mar 23

Phio Pharmaceuticals CEO to join Force Family Office fireside chat

Reuters
·
Mar 16

Phio Pharmaceuticals to present at the Life Sciences Investor Forum at 11 a.m. ET

Reuters
·
Mar 10

Phio Pharma Q4 EPS $(0.15) Beats $(0.41) Estimate

Benzinga
·
Mar 06

Phio (PHIO) FY 2025 net loss widened to USD 8.7 million

Reuters
·
Mar 06

Phio Pharmaceuticals to Present at Renmark Financial Communications Live Virtual Non-Deal Roadshow Series

Reuters
·
Mar 05